跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 61,477 条关于
“MSI-high tumors”
全部
61,477
临床试验
42,253
药物
1,208
机构
334
资讯
17,682
去年
IDEAYA Biosciences' Werner Helicase Inhibitor IDE275 Cleared for Phase 1 Trial in MSI-High Solid Tumors
去年
Novartis' Oral WRN Helicase Inhibitor HRO761 Targets MSI-High and dMMR Tumors
去年
Vividion Secures Exclusive Rights to First-in-Class WRN Inhibitor VVD-214 for MSI-High Cancers
8个月前
Vividion's WRN Inhibitor VVD-214 Shows Promise for MSI-High Cancers in Journal of Medicinal Chemistry Publication
9个月前
Nimbus Therapeutics Completes Dose Escalation for Novel WRN Inhibitor NDI-219216 in MSI-H Tumors
8个月前
Eikon Therapeutics Files for $100 Million IPO to Advance Late-Stage Cancer Pipeline
去年
FDA Approves MI Cancer Seek as Companion Diagnostic for Targeted Therapy Across Tumor Types
去年
Nimbus Therapeutics Initiates First-in-Human Trial of NDI-219216 for MSI-H Tumors Resistant to Standard Therapies
10个月前
WRN Inhibitors Enter Clinical Development Phase as Precision Oncology Market Expands
去年
IDEAYA Biosciences Advances Precision Medicine Pipeline with Multiple Clinical Programs
第 1 页,共 1769 页
上一页
下一页